- CA$1.54bn
- CA$1.49bn
- CA$253.35m
- 80
- 67
- 49
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 204 | -9.54 | 303 | -79.1 | 253 |
Cost of Revenue | |||||
Gross Profit | 195 | -18.4 | 292 | -91.3 | 239 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 13.7 | 13.5 | 17.1 | 17.7 | 20.1 |
Operating Profit | 191 | -23 | 286 | -96.8 | 233 |
Net Income Before Taxes | 191 | -23 | 286 | -96.8 | 233 |
Provision for Income Taxes | |||||
Net Income After Taxes | 170 | -13.8 | 254 | -80.6 | 206 |
Net Income Before Extraordinary Items | |||||
Net Income | 170 | -13.8 | 254 | -80.6 | 206 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 170 | -13.8 | 254 | -80.6 | 206 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.49 | -0.605 | 11.1 | -3.54 | 9.08 |